Blinded validation of breath biomarkers of lung cancer, a potential ancillary to chest ct screening

HIGHLIGHTS

• who: Michael Phillips et al. from the Breath Research Laboratory, Menssana Research Inc, Warren St, Newark, NJ, United States Warren Street, Newark, NJ, United States of America, New York University Langone Medical have published the article: Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0142484]. December 23, 2015 of October/22,/2015
• what: The authors report here a blinded replicated two-phase clinical study of breath biomarkers of lung cancer that was designed to minimize potential sources of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.